Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2025-12-25 @ 1:40 AM
NCT ID:
NCT00437294
Eligibility Criteria:
Inclusion Criteria:
* Have been diagnosed with metastatic or recurrent breast cancer.
* Have been previously treated with both an anthracycline and a taxane.
* Have not received more than two prior chemotherapy treatment programs.
* Have stopped any antitumoral hormonal treatment before you enroll in this study.
* Have a negative pregnancy blood test if menstruating or capable of becoming pregnant. You must use an approved birth control method during the study and for 3 months after stopping study treatment.
Exclusion Criteria:
* Cannot follow the study procedures (for example, you cannot swallow tablets).
* Are receiving another treatment for your cancer.
* Have received another experimental drug in the last 4 weeks.
* Have had serious heart disease within last 6 months.
* Are pregnant or breast-feeding.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT00437294
Study Brief:
Protocol Section:
NCT00437294